Fluticasone Furoate/GW642444 Inhalation Powder
Sponsors
GlaxoSmithKline
Conditions
Asthma
Phase 3
Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis
CompletedNCT01086410
Start: 2010-03-31End: 2010-09-30Updated: 2017-01-18
A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma
CompletedNCT01244984
Start: 2010-07-31End: 2012-01-31Updated: 2017-01-11